Clinical trials are expected to start in the second half of 2023, with topline data due in 2024
doi: 10.1038/s41467-020-19793-8 48
Possible semaglutide side effects include: Nausea Vomiting Diarrhea Constipation Mild Abdominal pain or stomach pain Headache Fatigue Traditional weight loss drugs often contain stimulants that can increase heart rate and blood pressure, leading to potential cardiovascular issues like the risk of heart attack
CAGRILINTIDE 5 MG Analog amyliny Aktywuje mzgowe receptory amyliny syto i zmniejszone spoycie kalorii
As well, in real-world scenarios, such as described by Brindisi et al, it is mentioned a reduction in pleasure and taste perception in overweight and people with obesity with poor type 2 diabetes control, probably by lowering the detection threshold of sweet flavors, becoming more sensitive to them, resulting in aversion for this flavor (175)
The whole issue of not as many people [qualifying for military service] because of obesity, because of behavioral issues thats going to continue, Army Secretary Christine Wormuth said at the annual Defense News Conference in September
